Detalhe da pesquisa
1.
High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020-April 2021), Democratic Republic of the Congo.
Emerg Infect Dis
; 29(1): 89-97, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36573545
2.
High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
Clin Infect Dis
; 74(5): 882-890, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089598